Characteristics associated with differences in survival among black and white women with breast cancer.

IMPORTANCE Difference in breast cancer survival by race is a recognized problem among Medicare beneficiaries. OBJECTIVE To determine if racial disparity in breast cancer survival is primarily attributable to differences in presentation characteristics at diagnosis or subsequent treatment. DESIGN, SETTING, AND PATIENTS Comparison of 7375 black women 65 years and older diagnosed between 1991 to 2005 and 3 sets of 7375 matched white control patients selected from 99,898 white potential controls, using data for 16 US Surveillance, Epidemiology and End Results (SEER) sites in the SEER-Medicare database. All patients received follow-up through December 31, 2009, and the black case patients were matched to 3 white control populations on demographics (age, year of diagnosis, and SEER site), presentation (demographics variables plus patient comorbid conditions and tumor characteristics such as stage, size, grade, and estrogen receptor status), and treatment (presentation variables plus details of surgery, radiation therapy, and chemotherapy). MAIN OUTCOMES AND MEASURES 5-Year survival. RESULTS The absolute difference in 5-year survival (blacks, 55.9%; whites, 68.8%) was 12.9% (95% CI, 11.5%-14.5%; P < .001) in the demographics match. This difference remained unchanged between 1991 and 2005. After matching on presentation characteristics, the absolute difference in 5-year survival was 4.4% (95% CI, 2.8%-5.8%; P < .001) and was 3.6% (95% CI, 2.3%-4.9%; P < .001) lower for blacks than for whites matched also on treatment. In the presentation match, fewer blacks received treatment (87.4% vs 91.8%; P < .001), time from diagnosis to treatment was longer (29.2 vs 22.8 days; P < .001), use of anthracyclines and taxols was lower (3.7% vs 5.0%; P < .001), and breast-conserving surgery without other treatment was more frequent (8.2% vs 7.3%; P = .04). Nevertheless, differences in survival associated with treatment differences accounted for only 0.81% of the 12.9% survival difference. CONCLUSIONS AND RELEVANCE In the SEER-Medicare database, differences in breast cancer survival between black and white women did not substantially change among women diagnosed between 1991 and 2005. These differences in survival appear primarily related to presentation characteristics at diagnosis rather than treatment differences.

[1]  P. Tartter,et al.  Noncompliance with adjuvant radiation, chemotherapy, or hormonal therapy in breast cancer patients. , 2008, American journal of surgery.

[2]  A. Neugut,et al.  Racial disparities in treatment and survival among women with early-stage breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  D. Rubin,et al.  The central role of the propensity score in observational studies for causal effects , 1983 .

[4]  J. D. Holt,et al.  Survival analyses in twin studies and matched pair experiments , 1974 .

[5]  J. Heck,et al.  Delays in breast cancer diagnosis and treatment by racial/ethnic group. , 2006, Archives of internal medicine.

[6]  J. Kalbfleisch,et al.  The Statistical Analysis of Failure Time Data , 1980 .

[7]  P. Rosenbaum.  An exact distribution‐free test comparing two multivariate distributions based on adjacency , 2005 .

[8]  Deborah Schrag,et al.  Overview of the SEER-Medicare Data: Content, Research Applications, and Generalizability to the United States Elderly Population , 2002, Medical care.

[9]  Dawn L Hershman,et al.  Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  E. Guadagnoli,et al.  Patient Demographic and Socioeconomic Characteristics in the SEER-Medicare Database: Applications and Limitations , 2002, Medical care.

[11]  A. Troxel,et al.  Regional and racial disparities in breast cancer-specific mortality. , 2006, Social science & medicine.

[12]  R. Deyo,et al.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.

[13]  Robert Tibshirani,et al.  Bootstrap Methods for Standard Errors, Confidence Intervals, and Other Measures of Statistical Accuracy , 1986 .

[14]  X Zhang,et al.  Multivariate Matching and Bias Reduction in the Surgical Outcomes Study , 2001, Medical care.

[15]  Katrina Armstrong,et al.  An Algorithm for Optimal Tapered Matching, With Application to Disparities in Survival , 2008, Journal of computational and graphical statistics : a joint publication of American Statistical Association, Institute of Mathematical Statistics, Interface Foundation of North America.

[16]  P. Rosenbaum,et al.  Minimum Distance Matched Sampling With Fine Balance in an Observational Study of Treatment for Ovarian Cancer , 2007 .

[17]  K. Schwartz,et al.  Increased racial differences on breast cancer care and survival in America: historical evidence consistent with a health insurance hypothesis, 1975–2001 , 2009, Breast Cancer Research and Treatment.

[18]  K. McMasters,et al.  Primary tumor size, not race, determines outcomes in women with hormone-responsive breast cancer. , 2011, Surgery.

[19]  Hoangmai H Pham,et al.  Care patterns in Medicare and their implications for pay for performance. , 2007, The New England journal of medicine.

[20]  D. Rubin,et al.  Constructing a Control Group Using Multivariate Matched Sampling Methods That Incorporate the Propensity Score , 1985 .

[21]  D. Nerenz,et al.  Comorbidity and survival disparities among black and white patients with breast cancer. , 2005, JAMA.

[22]  S. Ooi,et al.  Disparities in breast cancer characteristics and outcomes by race/ethnicity , 2011, Breast Cancer Research and Treatment.

[23]  T. Byers,et al.  The impact of socioeconomic status on survival after cancer in the United States , 2008, Cancer.

[24]  Dylan S. Small,et al.  Using the Cross-Match Test to Appraise Covariate Balance in Matched Pairs , 2010 .

[25]  Stephen E. Fienberg,et al.  Discrete Multivariate Analysis: Theory and Practice , 1976 .

[26]  P. Rosenbaum,et al.  Mortality among patients in VA hospitals in the first 2 years following ACGME resident duty hour reform. , 2007, JAMA.

[27]  W. G. Cochran,et al.  Controlling Bias in Observational Studies: A Review. , 1974 .

[28]  A. Recht,et al.  Race, socioeconomic status, and breast carcinoma in the U.S. , 2002, Cancer.

[29]  D. Wolfe,et al.  Nonparametric Statistical Methods. , 1974 .

[30]  J. Stockman.  Mortality Among Hospitalized Medicare Beneficiaries in the First 2 Years Following ACGME Resident Duty Hour Reform , 2009 .

[31]  Thomas R. Fleming,et al.  A paired prentice-Wilcoxon test for censored paired data , 1987 .

[32]  Deborah Schrag,et al.  Primary care physicians who treat blacks and whites. , 2004, The New England journal of medicine.

[33]  D. Rubin.  For objective causal inference, design trumps analysis , 2008, 0811.1640.

[34]  J L Warren,et al.  Development of a comorbidity index using physician claims data. , 2000, Journal of clinical epidemiology.

[35]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[36]  C. Earle,et al.  Racial segregation and disparities in breast cancer care and mortality , 2008, Cancer.

[37]  C. Borror.  Nonparametric Statistical Methods, 2nd, Ed. , 2001 .

[38]  C. Klabunde,et al.  A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients. , 2007, Annals of epidemiology.

[39]  Rebecca Smith-Bindman,et al.  Racial and ethnic differences in breast cancer survival , 2008, Cancer.

[40]  D. Miglioretti,et al.  Does Utilization of Screening Mammography Explain Racial and Ethnic Differences in Breast Cancer? , 2006, Annals of Internal Medicine.

[41]  S. Coughlin,et al.  Mammography Use Helps To Explain Differences in Breast Cancer Stage at Diagnosis between Older Black and White Women , 1998, Annals of Internal Medicine.

[42]  Timothy L Lash,et al.  Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  A. Neugut,et al.  Within‐stage racial differences in tumor size and number of positive lymph nodes in women with breast cancer , 2007, Cancer.

[44]  C. Perou,et al.  Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. , 2006, JAMA.

[45]  P. Rosenbaum,et al.  Using the Exterior Match to Compare Two Entwined Matched Control Groups , 2013 .

[46]  Ahmedin Jemal,et al.  Cancer Disparities by Race/Ethnicity and Socioeconomic Status , 2004, CA: a cancer journal for clinicians.

[47]  Dylan S Small,et al.  Optimal Matching with Minimal Deviation from Fine Balance in a Study of Obesity and Surgical Outcomes , 2012, Biometrics.

[48]  Laurence L. George,et al.  The Statistical Analysis of Failure Time Data , 2003, Technometrics.

[49]  P. Rosenbaum,et al.  Medical and Financial Risks Associated With Surgery in the Elderly Obese , 2012, Annals of surgery.

[50]  F. Camacho,et al.  Adjuvant hormonal therapy use among insured, low-income women with breast cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[51]  P. Rosenbaum,et al.  Invited commentary: propensity scores. , 1999, American journal of epidemiology.

[52]  D. Rubin.  The design versus the analysis of observational studies for causal effects: parallels with the design of randomized trials , 2007, Statistics in medicine.

[53]  D. Rubin.  Using Propensity Scores to Help Design Observational Studies: Application to the Tobacco Litigation , 2001, Health Services and Outcomes Research Methodology.